Delivery Order SPE2DB22D2206-SPE2DB26FDU17
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules in a quantity of 100 units, with a ceiling value of $1,020.66. This is a firm fixed price delivery order with an ultimate completion date of October 23, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,036.49 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,987.51 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,552.79 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This competitively awarded, firm fixed-price contract is not set-aside and was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,376.87 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,745.29 on August 20, 2025, for the supply of Methylphenidate ER(CD) 30mg capsules (100 count). This is a firm fixed-price, non-set-aside contract with a completion date of August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylphenidate ER(LA) 20mg in quantities of 100 capsules. This is a firm fixed price delivery order with a ceiling value of $2,169.84 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation, and performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $1,628.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units). The order, issued on October 17, 2025, with completion scheduled for October 20, 2025, represents a non-competitive, non-set-aside procurement under the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,991.73 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg, 100-count capsules. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and was awarded on October 22, 2025. The contract involves no set-aside designation, indicating it was competitively awarded. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDU17Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,668.68 on October 27, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This competitively awarded, firm fixed-price contract is not subject to any set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that specializes in supplying a broad range of medications and medical supplies to support federal medical procurement needs. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive experience fulfilling pharmaceutical orders across multiple therapeutic domains for military and veteran healthcare systems. This specific delivery order for methylphenidate, a common central nervous system stimulant used in attention-deficit/hyperactivity disorder treatment, reflects the company's role as a critical vendor for the federal healthcare supply chain supporting Department of Defense medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 10/27/25 |